Sinclair Pharma PLC (LSE:SPH) - Share price - Overview

Stock Report

Sinclair Pharma PLC SPH

Last Price
GBX18.58

Day Change
0.00|0.00%

As of 25/06/2018
15:25:52 BST | GBX
Minimum 15 Minutes Delay.

Last Close18.58p
Day Range18.60 - 19.17
Mkt Cap93.58Mil
52-Wk Range14.45 - 33.00
Yield %-
ISINGB0033856740
Volume1,343,905
P/E-152.25
P/S0.02
P/CF-0.08

Share Price

Total Returns 22/06/2018

 Chg (%)  
More ...
Sinclair Pharma PLC24.87 
FTSE 100 TR GBP-2.14
 
Financials
201520162017
More ...
Income Statement
Turnover27.8424.9245.30
Operating Profit-11.19-11.11-2.11
Net Profit-23.37-24.62-0.67
Reported EPS-4.70-5.00-0.13
Balance Sheet
Current Assets47.95-23.04
Non Current Assets237.47-145.83
Total Assets285.42-168.88
Current Liabilities46.75-20.17
Total Liabilities179.85-69.69
Total Equity105.57-99.18
Cash Flow
Operating Cash Flow4.79-15.54-10.89
Net Change in Cash-5.0911.12-14.85
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
16/01/2018PurchaseMr. Jeffery Scott Thompson23.10200,00046,200.00
16/01/2018PurchaseMr. Christopher P Spooner23.15200,00046,300.00

Company Profile

Sinclair Pharma PLC is a specialty pharmaceutical company focused on Dermatology, in particular - Aesthetics, Wound care, and Skin care.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM All-Share

Next Event 19/09/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-2.75
Op Mrgn-0.05
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. Jeffery Scott Thompson
Executive Director, Chief Executive OfficerMr. Christopher P Spooner
Executive Director, Chief Financial OfficerAlan Musgrave Olby
Non-Executive Director, ChairmanMr. Grahame David Cook
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.